VBI Vaccines IncVBIV

Market cap
$1.55M
P/E ratio
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
NET LOSS-23-39-64-55-46-70-113
Depreciation and amortization1111222
Stock-based compensation323451010
Amortization of debt discount0111232
Loss on extinguishment of long-term debt-------0
Inventory reserve----101
Unrealized foreign exchange loss (gain)-------27
Change in accounts receivable-0-0-00-0-00
Change in inventory0000216
Change in prepaid expenses-00-011-0
Change in other current assets-00-0-08-63
Change in other long-term assets000-0-010
Change in operating right of use assets-----1-1-1
Change in accounts payable0-14-5209
Change in deferred revenues--5-2-1-00
Change in other current liabilities3540-111-3
Payments made on operating lease liabilities------1
Net cash flows used in operating activities-19-31-46-49-47-40-74
Purchase of property and equipment1164124
Net cash flows used in/ provided by investing activities2-1-6-4-2623-4
Proceeds from issuance of common shares for in financing transactions2472474012233-
Share issuance costs-53361-
Proceeds from issuance of common shares upon exercise of warrants----20-
Proceeds from issuance of common shares upon exercise of stock options000-000
Proceeds from debt financing----201220
Debt issuance costs----101
Net cash flows provided by financing activities366744371224419
Effect of exchange rates on cash---1-000-0
CHANGE IN CASH FOR THE YEAR---8-155028-59
Interest paid-222223
Adjustments for prior periods from adoption of ASU 2020-06------1
Warrant modification in connection with debt amendment------1-
Warrants issued in connection with financing transactions------2
Common shares issued in connection with cashless warrant exercise-----4-
Capital expenditures included in accounts payable and other current liabilities-----00
Share issuance costs included in accounts payable and other current liabilities-----0-00